| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 242,4 k € | -44.2% | 434,3 k € | +56.7% | 277,2 k € | +669.2% | -48,7 k € | +71.8% | -172,5 k € | -109.8% | 1,8 M € | +170.9% | -2,5 M € | -67458.8% | -3,7 k € | |
| EBITDA | -498,2 k € | +0.7% | -501,5 k € | -47.8% | -339,3 k € | +39.5% | -560,5 k € | +18.3% | -686,1 k € | -159.4% | 1,2 M € | +143.5% | -2,7 M € | -72243.1% | -3,7 k € | |
| Operating profit | -2,1 M € | +24.0% | -2,8 M € | -21.7% | -2,3 M € | -4.6% | -2,2 M € | -4.8% | -2,1 M € | -708.3% | 341,1 k € | +112.8% | -2,7 M € | -72449.2% | -3,7 k € | |
| Profit/loss | -1,1 M € | +31.2% | -1,6 M € | -9.3% | -1,4 M € | -0.6% | -1,4 M € | -4.3% | -1,4 M € | -278.9% | 770,2 k € | +128.9% | -2,7 M € | -72607.8% | -3,7 k € | |
| Equity | 2,6 M € | -42.4% | 4,4 M € | -36.6% | 7,0 M € | +42.1% | 4,9 M € | +13.2% | 4,3 M € | -29.4% | 6,2 M € | +164.6% | 2,3 M € | +369.3% | 496,3 k € | |
| Total assets | 3,9 M € | -31.4% | 5,6 M € | -28.4% | 7,9 M € | +26.4% | 6,2 M € | +5.1% | 5,9 M € | -21.7% | 7,6 M € | +173.9% | 2,8 M € | +435.8% | 515,8 k € | |
| Cash | 240,3 k € | -17.3% | 290,5 k € | -68.1% | 910,5 k € | +190.4% | 313,6 k € | +1209.6% | 23,9 k € | -96.6% | 710,1 k € | -47.9% | 1,4 M € | +172.3% | 500,0 k € | |
| Debts | 1,3 M € | +9.2% | 1,2 M € | +36.2% | 883,3 k € | -32.6% | 1,3 M € | -17.1% | 1,6 M € | +12.8% | 1,4 M € | +222.7% | 434,3 k € | +2132.3% | 19,5 k € | |
| Staff | 4,8 | 5,8 | 5,1 | 3,8 | 4,6 | — | — | — | ||||||||
Public limited company · Charleroi · incorporated on 28/11/2018 · 4,8 ETP
Public limited company loss-making in the latest fiscal year. Cash position declining (-17.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Minoryx Therapeutics BE is a Public limited company incorporated in 2018. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Charleroi. It employs on average 4,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette